Multi-Company, Multi-Product Clinical Trials On The Cards For Rare Pediatric Diseases

Industry is guardedly optimistic about a new joint proposal from US and EU regulators for companies to test their drugs for rare pediatric diseases together in single multi-product studies.

Medication
US and EU regulatrs want companies to collaborate on drugs for rare pediatric diseases • Source: Shutterstock

More from Europe

More from Geography